 | • レポートコード：MRC2Q12-19247 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、硫酸モルヒネのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 硫酸モルヒネのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 硫酸モルヒネの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 硫酸モルヒネのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの硫酸モルヒネの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の硫酸モルヒネの売上および2028年までの予測に焦点を当てています。 硫酸モルヒネのグローバル主要企業には、Mundi Pharma、Bard Pharma、Qinhai Zhiyao、Nepharm、Mayinglong、Padagis、Piramal Enterprises、Actavis、Akacia Healthcare、AbbVie、Allied Drug、Angelini Pharma、ANI Pharma、Apotex、Arrow Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 硫酸モルヒネ市場は、タイプとアプリケーションによって区分されます。世界の硫酸モルヒネ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、注射液、内服液 【アプリケーション別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 硫酸モルヒネ製品概要 - タイプ別市場（錠剤、注射液、内服液） - アプリケーション別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の硫酸モルヒネ販売量予測2017-2028 - 世界の硫酸モルヒネ売上予測2017-2028 - 硫酸モルヒネの地域別販売量 - 硫酸モルヒネの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別硫酸モルヒネ販売量 - 主要メーカー別硫酸モルヒネ売上 - 主要メーカー別硫酸モルヒネ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、注射液、内服液） - 硫酸モルヒネのタイプ別販売量 - 硫酸モルヒネのタイプ別売上 - 硫酸モルヒネのタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、その他） - 硫酸モルヒネのアプリケーション別販売量 - 硫酸モルヒネのアプリケーション別売上 - 硫酸モルヒネのアプリケーション別価格 ・北米市場 - 北米の硫酸モルヒネ市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸モルヒネ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの硫酸モルヒネ市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸モルヒネ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の硫酸モルヒネ市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸モルヒネ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の硫酸モルヒネ市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸モルヒネ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの硫酸モルヒネ市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸モルヒネ市場規模（トルコ、サウジアラビア） ・企業情報 Mundi Pharma、Bard Pharma、Qinhai Zhiyao、Nepharm、Mayinglong、Padagis、Piramal Enterprises、Actavis、Akacia Healthcare、AbbVie、Allied Drug、Angelini Pharma、ANI Pharma、Apotex、Arrow Pharma ・産業チェーン及び販売チャネル分析 - 硫酸モルヒネの産業チェーン分析 - 硫酸モルヒネの原材料 - 硫酸モルヒネの生産プロセス - 硫酸モルヒネの販売及びマーケティング - 硫酸モルヒネの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 硫酸モルヒネの産業動向 - 硫酸モルヒネのマーケットドライバー - 硫酸モルヒネの課題 - 硫酸モルヒネの阻害要因 ・主な調査結果 |
Morphine sulfate extended-release tablets are powerful analgesics, mainly suitable for analgesia in patients with severe cancer pain
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Morphine Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Morphine Sulphate include Mundi Pharma, Bard Pharma, Qinhai Zhiyao, Nepharm, Mayinglong, Padagis, Piramal Enterprises, Actavis and Akacia Healthcare, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Morphine Sulphate manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Morphine Sulphate market. Further, it explains the major drivers and regional dynamics of the global Morphine Sulphate market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mundi Pharma
Bard Pharma
Qinhai Zhiyao
Nepharm
Mayinglong
Padagis
Piramal Enterprises
Actavis
Akacia Healthcare
AbbVie
Allied Drug
Angelini Pharma
ANI Pharma
Apotex
Arrow Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by age form and by application segments based on sales, price, and value for the period 2017-2028.
Morphine Sulphate Segment Dosage Form
Tablets
Solution for Injection
Oral Liquid
Morphine Sulphate Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Morphine Sulphate market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Morphine Sulphate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Morphine Sulphate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Morphine Sulphate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Morphine Sulphate sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Morphine Sulphate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Morphine Sulphate sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mundi Pharma, Bard Pharma, Qinhai Zhiyao, Nepharm, Mayinglong, Padagis, Piramal Enterprises, Actavis and Akacia Healthcare, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Morphine Sulphate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Morphine Sulphate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by age form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by age form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by age form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by age form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by age form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morphine Sulphate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Morphine Sulphate Product Introduction
1.2 Market Dosage Form
1.2.1 Global Morphine Sulphate Market Size Growth Rate Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Solution for Injection
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Morphine Sulphate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Morphine Sulphate Sales Estimates and Forecasts 2017-2028
2.2 Global Morphine Sulphate Revenue Estimates and Forecasts 2017-2028
2.3 Global Morphine Sulphate Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Morphine Sulphate Sales by Region
2.4.1 Global Morphine Sulphate Sales by Region (2017-2022)
2.4.2 Global Sales Morphine Sulphate by Region (2023-2028)
2.5 Global Morphine Sulphate Revenue by Region
2.5.1 Global Morphine Sulphate Revenue by Region (2017-2022)
2.5.2 Global Morphine Sulphate Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Morphine Sulphate Sales by Manufacturers
3.1.1 Global Top Morphine Sulphate Manufacturers by Sales (2017-2022)
3.1.2 Global Morphine Sulphate Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Morphine Sulphate in 2021
3.2 Global Morphine Sulphate Revenue by Manufacturers
3.2.1 Global Morphine Sulphate Revenue by Manufacturers (2017-2022)
3.2.2 Global Morphine Sulphate Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Morphine Sulphate Revenue in 2021
3.3 Global Morphine Sulphate Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Morphine Sulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Morphine Sulphate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size Dosage Form
4.1 Global Morphine Sulphate Sales Dosage Form
4.1.1 Global Morphine Sulphate Historical Sales Dosage Form (2017-2022)
4.1.2 Global Morphine Sulphate Forecasted Sales Dosage Form (2023-2028)
4.1.3 Global Morphine Sulphate Sales Market Share Dosage Form (2017-2028)
4.2 Global Morphine Sulphate Revenue Dosage Form
4.2.1 Global Morphine Sulphate Historical Revenue Dosage Form (2017-2022)
4.2.2 Global Morphine Sulphate Forecasted Revenue Dosage Form (2023-2028)
4.2.3 Global Morphine Sulphate Revenue Market Share Dosage Form (2017-2028)
4.3 Global Morphine Sulphate Price Dosage Form
4.3.1 Global Morphine Sulphate Price Dosage Form (2017-2022)
4.3.2 Global Morphine Sulphate Price Forecast Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Morphine Sulphate Sales by Application
5.1.1 Global Morphine Sulphate Historical Sales by Application (2017-2022)
5.1.2 Global Morphine Sulphate Forecasted Sales by Application (2023-2028)
5.1.3 Global Morphine Sulphate Sales Market Share by Application (2017-2028)
5.2 Global Morphine Sulphate Revenue by Application
5.2.1 Global Morphine Sulphate Historical Revenue by Application (2017-2022)
5.2.2 Global Morphine Sulphate Forecasted Revenue by Application (2023-2028)
5.2.3 Global Morphine Sulphate Revenue Market Share by Application (2017-2028)
5.3 Global Morphine Sulphate Price by Application
5.3.1 Global Morphine Sulphate Price by Application (2017-2022)
5.3.2 Global Morphine Sulphate Price Forecast by Application (2023-2028)
6 North America
6.1 North America Morphine Sulphate Market Size Dosage Form
6.1.1 North America Morphine Sulphate Sales Dosage Form (2017-2028)
6.1.2 North America Morphine Sulphate Revenue Dosage Form (2017-2028)
6.2 North America Morphine Sulphate Market Size by Application
6.2.1 North America Morphine Sulphate Sales by Application (2017-2028)
6.2.2 North America Morphine Sulphate Revenue by Application (2017-2028)
6.3 North America Morphine Sulphate Market Size by Country
6.3.1 North America Morphine Sulphate Sales by Country (2017-2028)
6.3.2 North America Morphine Sulphate Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Morphine Sulphate Market Size Dosage Form
7.1.1 Europe Morphine Sulphate Sales Dosage Form (2017-2028)
7.1.2 Europe Morphine Sulphate Revenue Dosage Form (2017-2028)
7.2 Europe Morphine Sulphate Market Size by Application
7.2.1 Europe Morphine Sulphate Sales by Application (2017-2028)
7.2.2 Europe Morphine Sulphate Revenue by Application (2017-2028)
7.3 Europe Morphine Sulphate Market Size by Country
7.3.1 Europe Morphine Sulphate Sales by Country (2017-2028)
7.3.2 Europe Morphine Sulphate Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Morphine Sulphate Market Size Dosage Form
8.1.1 Asia Pacific Morphine Sulphate Sales Dosage Form (2017-2028)
8.1.2 Asia Pacific Morphine Sulphate Revenue Dosage Form (2017-2028)
8.2 Asia Pacific Morphine Sulphate Market Size by Application
8.2.1 Asia Pacific Morphine Sulphate Sales by Application (2017-2028)
8.2.2 Asia Pacific Morphine Sulphate Revenue by Application (2017-2028)
8.3 Asia Pacific Morphine Sulphate Market Size by Region
8.3.1 Asia Pacific Morphine Sulphate Sales by Region (2017-2028)
8.3.2 Asia Pacific Morphine Sulphate Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Morphine Sulphate Market Size Dosage Form
9.1.1 Latin America Morphine Sulphate Sales Dosage Form (2017-2028)
9.1.2 Latin America Morphine Sulphate Revenue Dosage Form (2017-2028)
9.2 Latin America Morphine Sulphate Market Size by Application
9.2.1 Latin America Morphine Sulphate Sales by Application (2017-2028)
9.2.2 Latin America Morphine Sulphate Revenue by Application (2017-2028)
9.3 Latin America Morphine Sulphate Market Size by Country
9.3.1 Latin America Morphine Sulphate Sales by Country (2017-2028)
9.3.2 Latin America Morphine Sulphate Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Morphine Sulphate Market Size Dosage Form
10.1.1 Middle East and Africa Morphine Sulphate Sales Dosage Form (2017-2028)
10.1.2 Middle East and Africa Morphine Sulphate Revenue Dosage Form (2017-2028)
10.2 Middle East and Africa Morphine Sulphate Market Size by Application
10.2.1 Middle East and Africa Morphine Sulphate Sales by Application (2017-2028)
10.2.2 Middle East and Africa Morphine Sulphate Revenue by Application (2017-2028)
10.3 Middle East and Africa Morphine Sulphate Market Size by Country
10.3.1 Middle East and Africa Morphine Sulphate Sales by Country (2017-2028)
10.3.2 Middle East and Africa Morphine Sulphate Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mundi Pharma
11.1.1 Mundi Pharma Corporation Information
11.1.2 Mundi Pharma Overview
11.1.3 Mundi Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mundi Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mundi Pharma Recent Developments
11.2 Bard Pharma
11.2.1 Bard Pharma Corporation Information
11.2.2 Bard Pharma Overview
11.2.3 Bard Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bard Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bard Pharma Recent Developments
11.3 Qinhai Zhiyao
11.3.1 Qinhai Zhiyao Corporation Information
11.3.2 Qinhai Zhiyao Overview
11.3.3 Qinhai Zhiyao Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Qinhai Zhiyao Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Qinhai Zhiyao Recent Developments
11.4 Nepharm
11.4.1 Nepharm Corporation Information
11.4.2 Nepharm Overview
11.4.3 Nepharm Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nepharm Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nepharm Recent Developments
11.5 Mayinglong
11.5.1 Mayinglong Corporation Information
11.5.2 Mayinglong Overview
11.5.3 Mayinglong Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mayinglong Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mayinglong Recent Developments
11.6 Padagis
11.6.1 Padagis Corporation Information
11.6.2 Padagis Overview
11.6.3 Padagis Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Padagis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Padagis Recent Developments
11.7 Piramal Enterprises
11.7.1 Piramal Enterprises Corporation Information
11.7.2 Piramal Enterprises Overview
11.7.3 Piramal Enterprises Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Piramal Enterprises Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Enterprises Recent Developments
11.8 Actavis
11.8.1 Actavis Corporation Information
11.8.2 Actavis Overview
11.8.3 Actavis Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Actavis Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Actavis Recent Developments
11.9 Akacia Healthcare
11.9.1 Akacia Healthcare Corporation Information
11.9.2 Akacia Healthcare Overview
11.9.3 Akacia Healthcare Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Akacia Healthcare Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Akacia Healthcare Recent Developments
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AbbVie Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
11.11 Allied Drug
11.11.1 Allied Drug Corporation Information
11.11.2 Allied Drug Overview
11.11.3 Allied Drug Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Allied Drug Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Allied Drug Recent Developments
11.12 Angelini Pharma
11.12.1 Angelini Pharma Corporation Information
11.12.2 Angelini Pharma Overview
11.12.3 Angelini Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Angelini Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angelini Pharma Recent Developments
11.13 ANI Pharma
11.13.1 ANI Pharma Corporation Information
11.13.2 ANI Pharma Overview
11.13.3 ANI Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ANI Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ANI Pharma Recent Developments
11.14 Apotex
11.14.1 Apotex Corporation Information
11.14.2 Apotex Overview
11.14.3 Apotex Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Apotex Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Apotex Recent Developments
11.15 Arrow Pharma
11.15.1 Arrow Pharma Corporation Information
11.15.2 Arrow Pharma Overview
11.15.3 Arrow Pharma Morphine Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Arrow Pharma Morphine Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Arrow Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Morphine Sulphate Industry Chain Analysis
12.2 Morphine Sulphate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Morphine Sulphate Production Mode & Process
12.4 Morphine Sulphate Sales and Marketing
12.4.1 Morphine Sulphate Sales Channels
12.4.2 Morphine Sulphate Distributors
12.5 Morphine Sulphate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Morphine Sulphate Industry Trends
13.2 Morphine Sulphate Market Drivers
13.3 Morphine Sulphate Market Challenges
13.4 Morphine Sulphate Market Restraints
14 Key Findings in The Global Morphine Sulphate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer